/ Press Release Details /

Point of Care (Poc) Diagnostics Market Size Worth $21.8 Billion By 2025 | CAGR: 7.1%

The global point of care (PoC) diagnostics market is expected to grow at growth rate of 7.1% to reach USD 21.8 billion by 2025.

Point of care testing is rapidly growing diagnostic technique to produce quality laboratory results in short time period. These molecular tests are simple to use, fast, portable and inexpensive. Due to these benefits, a point of care testing is increasingly used by end-users to test cholesterol and glucose levels, test for drugs of abuse, enzyme analysis, for pregnancy testing and various other reasons.

Increasing incidence of target diseases is anticipated to stimulate the uptake of a point of care testing, driving the market growth. For instance, annually, large number of population dies due to cardiovascular disease.  According to estimates from the World Health Organization (WHO), around 17.7 million people died from the cardiovascular disorders in 2015 which is projected to reach 23.3 million deaths by 2030. Such facts will boost the utilization of these tests, hence support the market growth. However, regulatory issues will pull back the market growth to some extent.

Key Takeaways :

  • Growing prevalence of target diseases such as diabetes, cancer, cardiovascular diseases and infectious diseases is projected to serve this market as a high impact rendering driver
  • Government contracts primarily contributing towards the development of point of care diagnostics equipment in European countries
  • Blood glucose point of care testing accounted for the largest share of the market owing to the rising diabetes incidences coupled with sheer volume of these tests marketed and currently under usage
  • Hospitals recorded the highest revenue in 2017, expanding at 3.3% growth rate in future due to the rising adoption of point of care diagnostic testing
  • The U.S. captured the largest share of the global market. The growth of this country is majorly attributed to the rise in demand for POC testing and increasing prevalence of target disease.
  • Tough competition among leading market players. Roche Diagnostics, Abbott Laboratories, Danaher Corporation, and Siemens is considered to be the most dominating participants of the market owing to the extensive product portfolio and aggressive business strategies

KEY BENEFITS OF THE REPORT :

  • In-depth analysis of the key factors are propelling the growth of the global market
  • Granular analysis of the current market scenario and the expected market grow
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Highlight on the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation :

POC MARKET, BY PRODUCT

  • Glucose Testing
  • Hb1Ac Testing
  • Coagulation
  • Urinalysis
  • Fertility
  • Cardiac Markers
  • Infectious Diseases
  • Hematology
  • Decentralized Clinical Chemistry
  • Ambulatory Chemistry
  • Drug Abuse Testing
  • Others

POC MARKET, BY DISEASE CONDITION

  • Human Immunodeficiency Virus (HIV)
  • Respiratory Syncytial
  • Human papillomavirus (HPV)
  • Clostridium difficile
  • Hepatitis B
  • Pneumonia
  • Influenza
  • Hepatitis C
  • Tuberculosis
  • Others

POC MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

POC MARKET, BY COUNTRY

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2023. All rights reserved: AnalystView Market Insights